Increased regression and decreased incidence of human papillomavirus- related cervical lesions among HIV-infected women on HAART

AIDS

Volumn 26, Issue 13, 2012, Pages 1645-1652

  Adler, David H ^a   Kakinami, Lisa ^b   Modisenyane, Tebogo ^c   Tshabangu, Nkeko ^c   Mohapi, Lerato ^c   De Bruyn, Guy ^c   Martinson, Neil A ^c,d   Omar, Tanvier ^c  

^a UNIVERSITY OF ROCHESTER   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cervical cancer; disease progression; disease regression; HAART; Papanicolaou smear

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CIGARETTE SMOKING; COHORT ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; HAZARD RATIO; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OBESITY; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SOUTH AFRICA; SURVIVAL RATE; TREATMENT DURATION; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS; WOMEN'S HEALTH;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALPHAPAPILLOMAVIRUS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; MULTIVARIATE ANALYSIS; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; SMOKING; SOUTH AFRICA; UTERINE CERVICAL NEOPLASMS;

EID: 84865469610     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32835536a3     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993; 269:729-730.
2. Yang BH, Bray FI, Parkin DM, Sellors JW, Zhang Z-F. Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost.Int J Cancer 2004; 109:418-424. (Pubitemid 38252771)
3. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55:244-265. (Pubitemid 34293391)
4. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348:518-527. (Pubitemid 36159887)
5. Clifford GM, Goncalves MA, Franceschi S. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 2006; 20:2337-2344. (Pubitemid 44789536)
6. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIVnegative women. J Natl Cancer Inst 1999; 91:226-236. (Pubitemid 29090991)
7. Levi JE, Kleter B, Quint WG, Fink MC, Canto CL, Matsubara R, et al. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 2002; 40:3341-3345. (Pubitemid 34977451)
8. Queiroz C, Travassos AG, Studart E, Araujo Filho JB, Sarno CK, Pinheiro CC. Prevalence of human papilloma virus in HIVpositive and HIV-negative patients in the State of Bahia: a pilot study. Braz J Infect Dis 2004; 8:356-362.
9. Levi JE, Fernandes S, Tateno AF, Motta E, Lima LP, Eluf-Neto J, et al. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women. Gynecol Oncol 2004; 92:225-231. (Pubitemid 38147396)
10. Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997; 337:1343-1349. (Pubitemid 27467768)
11. Massad LS, Ahdieh L, Benning L, Minkoff H, Greenblatt RM, Watts H, et al. Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study. J Acquir Immune Defic Syndr 2001; 27:432-442. (Pubitemid 32801071)
12. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000; 92:1823-1830.
13. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. Epidemiological fact sheet on HIV and AIDS: core data on epidemiology and response-South Africa. Geneva, Switzerland: World Health Organization; 2008.
14. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005; 55:74-108.
15. Omar T, Schwartz S, Hanrahan C, Modisenyane T, Tshabangu N, Golub JE, et al. Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort. AIDS 2011; 25:87-94.
16. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287:2114-2119. (Pubitemid 34437346)
17. Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 2009; 101:1120-1130.
18. Dal Maso L, Polesel J, Serraino D, Lise M, Piselli P, Falcini F, et al. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer 2009; 100:840-847.
19. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, et al.Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005; 97: 425-432. (Pubitemid 40528605)
20. Lillo FB, Ferrari D, Veglia F, Origoni M, Grasso MA, Lodini S, et al. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 2001; 184:547-551. (Pubitemid 32783544)
21. Schuman P, Ohmit SE, Klein RS, Duerr A, Cu-Uvin S, Jamieson DJ, et al. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 2003; 188:128-136. (Pubitemid 36829752)
22. Paramsothy P, Jamieson DJ, Heilig CM, Schuman PC, Klein RS, Shah KV, et al. The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol 2009; 113:26-31.
23. Heard I, Schmitz V, Costagliola D, Orth G, Kazatchkine MD. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 1998; 12:1459-1464. (Pubitemid 28369645)
24. Minkoff H, Ahdieh L, Massad LS, Anastos K, Watts DH, Melnick S, et al. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 2001; 15:2157-2164. (Pubitemid 33101823)
25. Heard I, Tassie JM, Kazatchkine MD, Orth G. Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women. AIDS 2002; 16:1799-1802.
26. Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, et al. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Natl Cancer Inst 2004; 96:1070-1076. (Pubitemid 39172408)
27. Del Mistro A, Bertorelle R, Franzetti M, Cattelan A, Torrisi A, Giordani MT, et al. Antiretroviral therapy and the clinical evolution of human papillomavirus-associated genital lesions in HIV-positive women. Clin Infect Dis 2004; 38:737-742. (Pubitemid 38333872)
28. Soncini E, Zoncada A, Condemi V, Antoni AD, Bocchialini E, Soregotti P. Reduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy. Acta Biomed 2007; 78:36-40.
29. Heard I, Potard V, Costagliola D. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women. Antivir Ther 2006; 11:1091-1096. (Pubitemid 44955185)
30. Minkoff H, Zhong Y, Burk RD, Palefsky JM, Xue X, Watts DH, et al. Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Infect Dis 2010; 201:681-690.
31. Katz IT, Essien T, Marinda ET, Gray GE, Bangsberg DR, Martinson NA, et al. Antiretroviral therapy refusal among newly diagnosed HIV-infected adults. AIDS 2011; 25:2177-2181.
32. Pierangeli A, Scagnolari C, Degener AM, Bucci M, Ciardi A, Riva E, et al. Type-specific human papillomavirus-DNA load in anal infection in HIV-positive men. AIDS 2008; 22:1929-1935.
33. Kang M, Cu-Uvin S. Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy. HIV Med 2012; 13:372-378.